CASTERA, SANTIAGO; ALBERTO, MARÍA FABIANA; WOODS, ADRIANA INÉS; DOS SANTOS, CÉLIA; TRINIDAD, JESICA; SÁNCHEZ-LUCEROS, ANALÍA

Relevance of ADAMTS13 antigenic levels in the characterization of pathological mechanisms associated with immune-mediated thrombotic thrombocytopenic purpura (iTTP)

ISTH 2023 Congress

Año: 2023;

JESICA TRINIDAD; MARÍA F ALBERTO; SANTIAGO CASTERA; FEDERICO MANNI; LAURA F ALCONCHER; ANALÍA SÁNCHEZ-LUCEROS; CÉLIA DOS SANTOS

Diagnóstico y monitoreo de la respuesta al tratamiento de pacientes con SUHa autoinmune: de la clínica al laboratorio.

Congreso CAHT 2022

Lugar: Ciudad Autonoma de Buenos Aires; Año: 2022;

CÉLIA DOS SANTOS; SANTIAGO CASTERA; JOSE FERNANDEZ; JULIETA SOLEDAD ROSALES; CARLOS G FONDEVILA; ALICIA CHAVARRI; FRANCO CRESCITELLI; SANTIAGO BOUGHEN; MARCELO IASTREBNER; OSVALDO GUERRERO; CARLOS AMELL MENCO; MARIELA GOMEZ; JACQUELINE GONZALEZ; MARÍA FABIANA ALBERTO; ANALÍA SÁNCHEZ-LUCEROS

MicroangiopatíasTrombóticas (MAT) asociadas a vacunas contra COVID-19: informe de 5 casos

Congreso CAHT 2022

Año: 2022;

CÉLIA DOS SANTOS; GUSTAVO GRELONI; MARÍA F ALBERTO; ANALÍA SÁNCHEZ-LUCEROS

Role of Soluble C5b-9 (sC5b-9) in Dosing Adjustments of Anti-complement Therapy during Pregnancy in a Patient with History of Atypical Hemolytic Uremic Syndrome (aHUS)

ISTH 2021 Virtual congress

Lugar: Philadelphia; Año: 2021;

CÉLIA DOS SANTOS; ALICIA CHAVARRI; MARÍA FABIANA ALBERTO; CARLOS G FONDEVILA; ANALÍA SÁNCHEZ-LUCEROS

Reccurence of atypical hemolytic uremic syndrome after COVID-19 vaccination

2nd Toronto Complement Conference

Año: 2021;

SABRINA ROTONDO; CÉLIA DOS SANTOS; MARÍA FABIANA ALBERTO; ANALÍA SÁNCHEZ-LUCEROS

Differential Expression of CD46 in Leukocytes by Flow Cytometry: Methodological Aspects

ISTH 2020 Virtual Congress

Año: 2020;

AMANDA TAYLOR; CÉLIA DOS SANTOS; NICOLO GHIRINGHELLI BORSA; MICHAEL JONES; SARAH ROBERTS; RENEE GOODFELLOW; EMILY ANDERSON; MARÍA FABIANA ALBERTO; YUZHOU ZHANG; GUSTAVO GRELONI; ANALÍA SÁNCHEZ-LUCEROS; RICHARD J.H. SMITH

Comprehensive Complement Analysis of atypical Hemolytic Uremic Syndrome in Argentina: a case study

17th European Meeting on Complement in Human Disease

Lugar: Madrid; Año: 2019;

CÉLIA DOS SANTOS; NICOLO GHIRINGHELLI BORSA; AMANDA TAYLOR; MICHAEL JONES; NATALIA MOGOLLÓN MOLINA; MARÍA F ALBERTO; RITA MARCELA FORTUNATO; MARTA ADRAGNA; GUSTAVO GRELONI; YUZHOU ZHANG; RICHARD J.H. SMITH; ANALÍA SÁNCHEZ-LUCEROS

Complement Abnormalities in a Cohort of Argentinean Patients with Atypical Hemolytic Uremic Syndrome

XXVII Congress of the International Society on Thrombosis and Haemostasis

Año: 2019;

CÉLIA DOS SANTOS; NATALIA MOGOLLÓN MOLINA; MARÍA F ALBERTO; MARÍA L ROMERO; ANALÍA SÁNCHEZ-LUCEROS

Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome in an Argentinean pediatric cohort

64th Annual Meeting of the Scientific Standardization Committee of the International Society on Thrombosis and Haemostasis

Lugar: Dublin; Año: 2018;

JUVENAL PAIVA; ANA C KEMPFER; MARÍA F ALBERTO; ADRIANA I WOODS ; CÉLIA DOS SANTOS; ANALÍA SÁNCHEZ-LUCEROS; MARÍA A LAZZARI

mRNA Identification of a Novel Isoform (ISF) and ISF3 from ADAMTS13 in Different Types of Cells

XXVIth Congress of the ISTH

Lugar: Berlin; Año: 2017;

CÉLIA DOS SANTOS; MARA AGAZZONI; MAGALI BARRENECHEA; JUVENAL PAIVA; MARÍA M CASINELLI; ANA C KEMPFER; MARÍA L ROMERO; MARÍA A LAZZARI; ANALÍA SÁNCHEZ-LUCEROS

Thrombotic Microangiopathies (TMA): First Report of 250 Cases from a Single Institution Experience in Latin America

XXVIth Congress of the ISTH

Lugar: Berlin; Año: 2017;

CÉLIA DOS SANTOS; RICHARD J H SMITH; ANA C KEMPFER; MARÍA M CASINELLI; GUSTAVO GRELONI; ANALÍA SÁNCHEZ-LUCEROS

Identification of two novel single nucleotide variants of the complement Factor H (CFH) and Factor I (CFI) genes in a familial form of atypical hemolytic uremic syndrome (aHUS)

62nd Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Lugar: Montpellier; Año: 2016;

CÉLIA DOS SANTOS; MARÍA F ALBERTO; JUVENAL PAIVA; MARÍA M CASINELLI; MARÍA A LAZZARI; ANA C KEMPFER; ANALÍA SÁNCHEZ-LUCEROS

VALIDACIÓN DE CONDICIONES DE PROCESAMIENTO Y ALMACENAMIENTO DE MUESTRAS DE SANGRE PARA LA DETERMINACIÓN DEL MARCADOR DE ACTIVACIÓN DE LA VÍA ALTERNATIVA DEL COMPLEMENTO C5B-9 EN PACIENTES CON MICROANGIOPATÍA TROMBÓTICA (MAT)

LX REUNIÓN DE LA SOCIEDAD ARGENTINA DE INVESTIGACIÓN CLÍNICA (SAIC)

Año: 2015;

CÉLIA DOS SANTOS; MARÍA F ALBERTO; JUVENAL PAIVA; MARÍA M CASINELLI; MARÍA A LAZZARI; ANA C KEMPFER; ANALÍA SÁNCHEZ-LUCEROS

CONDICIONES CRÍTICAS EN LA DETERMINACIÓN DEL COMPLEMENTO ACTIVADO C5B-9 PARA SU USO COMO HERRAMIENTA DE DIAGNÓSTICO Y MONITOREO DE PACIENTES CON MICROANGIOPATÍA TROMBÓTICA (MAT)

SAH 2015-XXII CONGRESO ARGENTINO DE HEMATOLOGIA

Año: 2015;

CÉLIA DOS SANTOS; RACHA KARAKY; DOMINIQUE RENOIR; YAMINA HAMMA-KOURBALI; JOSÉ COURTY; JEAN DELBÉ

Antitumorigenic effects of a mutant Heparin Affin Regulatory Peptide on the U87 MG glioblastoma cell line

3rd European Course of in vivo Preclinical Assays in Cancer Therapy

Año: 2010;